Synergistic Inhibitory Effect of Antisense Vascular Endothelial Growth Factor Cdna Transfection and IFNα or Signal Transduction Inhibitor 571 (STI571) on the K562 Cells

阮国瑞,刘艳荣,陈珊珊,于弘,常艳,付家瑜,李金兰,秦亚溱

DOI: https://doi.org/10.3321/j.issn:1671-167x.2002.01.007

2002-01-01

Abstract:Objective: To investigate the co operative effect of antisense VEGF 121 cDNA transfection and IFNα or STI571 on the chronic myeloid leukemia(CML) cell line K562. Methods: K562 cells which were transfected with the VEGF 121 cDNA antisense (AS) or sense (S) vector, and with the vector (V, pcDNA3) alone were utilized. Effects of IFNα or STI571 on the proliferation and apoptosis of transfected K562 cells were studied by Trypan blue stain,flow cytometric Annexin V FITC/PI dual labeling technique. Results: Antisense VEGF 121 cDNA transfection in combination with IFNα 100 u·ml 1 , 1 000 u·ml 1 and 10 000 u·ml 1 could inhibit the proliferation, increase the apoptosis. STI571 (0.1 μmol·L 1 ) could inhibit the proliferation of all the transfected cells. VP16(10 mg·L 1 )or /and STI571(0.1 μmol·L 1 ) could induce more apoptosis in K562/AS cells after 24 h. STI571 (0.1 μmol·L 1 ) could induce the apoptosis of all the transfected cells after 72 h. Conclusion: Antisense VEGF 121 cDNA transfected K562 cells show that they can be synergetically inhibited cell growth with IFNα,and that they are more susceptible to low dose VP16 or /and STI571. This suggests anti VEGF medicine may be a new therapy strategy against CML.